产品名称 | NebuSelect™ Recombinant Human LILRB5/CD85c/LIR-8, Avi-His-tag |
---|---|
目录号 | NBL-242338 |
别名 | LILRB5/CD85c/LIR-8; CD85C ; LIR-8; LIR8 |
外观 | see COA |
分子量 | Arg18-His456 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O75023-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242338-100ug | 100ug | Inquire | Inquire | |
NBL-242338-1mg | 1mg | Inquire | Inquire | |
NBL-242338-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LILRB5/CD85c/LIR-8, Avi-His-tag
Catalog#:
NBL-242338
Description:
NebuSelect™ Recombinant Human LILRB5/CD85c/LIR-8, Avi-His-tag(Cat#NBL-242338) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Arg18-His456.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 49.9 kDa. Due to glycosylation, the protein migrates to 67-72 kDa based on Bis-Tris PAGE result.
Target Name:
LILRB5/CD85c/LIR-8; CD85C ; LIR-8; LIR8
Target Information:
LILRB5, also known as CD85c andLIR-8, belongs to a family of transmembrane glycoproteins that negatively regulate immune cell activation. Mature human LIR-8 consists of a 435 amino acid (aa) extracellular domain with four Ig-like domains, a 21 aa transmembrane segment, and a 111 aa cytoplasmic domain with two immunoreceptor tyrosine-based inhibitory motifs (ITIM). LILRB5 may act as receptor for class I MHC antigens.
Amino Acid Sequence:
Arg18-His456
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.